Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-007490

President and CEO gave up 3,579 shares (to pay taxes)

  • President and CEO acquired 10,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2019-02-01 Option exercise +10,800 920,924 D
Walker Neal President and CEO 2019-02-01 Shares withheld for taxes −3,579 $6.96 $24,910 917,345 D
Derivatives
Walker Neal President and CEO 2019-02-01 Option exercise · Restricted Stock Units −10,800 32,400 D
Loading xslF345X03/doc4.xml…